This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Japan Tobacco Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Akira Matsuo: Innovator in Pain Treatment
Introduction
Akira Matsuo is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of pain and interstitial cystitis. His innovative approach has led to the development of a unique therapeutic agent.
Latest Patents
Matsuo holds a patent for a method of treating pain or interstitial cystitis using an indole compound. The patent describes a therapeutic or prophylactic agent comprising N-[2-(6,6-dimethyl-4,5,6,7-tetrahydro-H-indazol-3-yl)-1H-indol-6-yl]-N-methyl-(2S)-2-(morpholin-4-yl)propanamide or a pharmaceutically acceptable salt thereof. This invention represents a significant advancement in pain management.
Career Highlights
Matsuo is associated with Japan Tobacco Inc., where he continues to work on innovative solutions in the medical field. His dedication to research and development has positioned him as a key figure in his area of expertise.
Collaborations
Matsuo collaborates with talented individuals such as Yoshifumi Ueda and Mutsuyoshi Matsushita. Their combined efforts contribute to the advancement of therapeutic methods and innovations in pain treatment.
Conclusion
Akira Matsuo's work exemplifies the impact of innovation in medicine, particularly in addressing pain and interstitial cystitis. His contributions through patents and collaborations highlight the importance of research in improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile